Annual FCF
$11.72 M
+$12.15 M+2775.11%
31 December 2023
Summary:
Harvard Bioscience annual free cash flow is currently $11.72 million, with the most recent change of +$12.15 million (+2775.11%) on 31 December 2023. During the last 3 years, it has risen by +$3.79 million (+47.77%). HBIO annual FCF is now -22.57% below its all-time high of $15.13 million, reached on 31 December 2009.HBIO Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly FCF
-$1.95 M
-$141.00 K-7.78%
30 September 2024
Summary:
Harvard Bioscience quarterly free cash flow is currently -$1.95 million, with the most recent change of -$141.00 thousand (-7.78%) on 30 September 2024. Over the past year, it has dropped by -$5.91 million (-149.32%). HBIO quarterly FCF is now -124.55% below its all-time high of $7.96 million, reached on 31 December 2008.HBIO Quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM FCF
$160.00 K
-$5.91 M-97.37%
30 September 2024
Summary:
Harvard Bioscience TTM free cash flow is currently $160.00 thousand, with the most recent change of -$5.91 million (-97.37%) on 30 September 2024. Over the past year, it has dropped by -$10.76 million (-98.53%). HBIO TTM FCF is now -99.02% below its all-time high of $16.27 million, reached on 30 September 2009.HBIO TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
HBIO Free Cash Flow Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +2775.1% | -149.3% | -98.5% |
| 3 y3 years | +47.8% | -71.3% | -93.1% |
| 5 y5 years | +517.3% | -169.7% | -97.9% |
HBIO Free Cash Flow High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +2775.1% | -149.3% | +20.5% | -98.6% | +103.6% |
| 5 y | 5 years | at high | +2775.1% | -149.3% | +20.5% | -98.6% | +103.6% |
| alltime | all time | -22.6% | +615.5% | -124.5% | +20.5% | -99.0% | +103.6% |
Harvard Bioscience Free Cash Flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$1.95 M(+7.8%) | $160.00 K(-97.4%) |
| June 2024 | - | -$1.81 M(-365.3%) | $6.07 M(-43.8%) |
| Mar 2024 | - | $683.00 K(-78.9%) | $10.81 M(-7.7%) |
| Dec 2023 | $11.72 M(-2775.1%) | $3.24 M(-18.1%) | $11.72 M(+7.3%) |
| Sept 2023 | - | $3.96 M(+35.3%) | $10.92 M(+52.4%) |
| June 2023 | - | $2.93 M(+84.3%) | $7.17 M(+98.7%) |
| Mar 2023 | - | $1.59 M(-35.0%) | $3.61 M(-923.5%) |
| Dec 2022 | -$438.00 K(+427.7%) | $2.44 M(+1080.7%) | -$438.00 K(-86.0%) |
| Sept 2022 | - | $207.00 K(-132.8%) | -$3.12 M(-30.1%) |
| June 2022 | - | -$632.00 K(-74.3%) | -$4.47 M(+36.4%) |
| Mar 2022 | - | -$2.46 M(+919.5%) | -$3.28 M(+3847.0%) |
| Dec 2021 | -$83.00 K(-101.0%) | -$241.00 K(-78.9%) | -$83.00 K(-103.6%) |
| Sept 2021 | - | -$1.14 M(-302.8%) | $2.33 M(-48.2%) |
| June 2021 | - | $562.00 K(-23.6%) | $4.51 M(-25.3%) |
| Mar 2021 | - | $736.00 K(-66.2%) | $6.04 M(-23.9%) |
| Dec 2020 | $7.93 M(+16.1%) | $2.18 M(+110.6%) | $7.93 M(+5.2%) |
| Sept 2020 | - | $1.03 M(-50.6%) | $7.54 M(-19.0%) |
| June 2020 | - | $2.09 M(-20.5%) | $9.30 M(+22.6%) |
| Mar 2020 | - | $2.63 M(+47.6%) | $7.59 M(+11.2%) |
| Dec 2019 | $6.83 M(+259.8%) | $1.78 M(-36.4%) | $6.83 M(-9.8%) |
| Sept 2019 | - | $2.80 M(+643.5%) | $7.57 M(+146.1%) |
| June 2019 | - | $377.00 K(-79.8%) | $3.08 M(-19.6%) |
| Mar 2019 | - | $1.87 M(-26.0%) | $3.82 M(+101.4%) |
| Dec 2018 | $1.90 M(+1382.8%) | $2.52 M(-249.1%) | $1.90 M(-206.9%) |
| Sept 2018 | - | -$1.69 M(-250.3%) | -$1.78 M(-198.3%) |
| June 2018 | - | $1.13 M(-2039.7%) | $1.81 M(+98.9%) |
| Mar 2018 | - | -$58.00 K(-95.0%) | $908.00 K(+609.4%) |
| Dec 2017 | $128.00 K(-96.7%) | -$1.15 M(-160.9%) | $128.00 K(-94.8%) |
| Sept 2017 | - | $1.89 M(+733.0%) | $2.48 M(-28.9%) |
| June 2017 | - | $227.00 K(-127.1%) | $3.49 M(-12.7%) |
| Mar 2017 | - | -$838.00 K(-169.7%) | $4.00 M(+2.4%) |
| Dec 2016 | $3.90 M(-271.8%) | $1.20 M(-58.5%) | $3.90 M(+3.1%) |
| Sept 2016 | - | $2.90 M(+294.3%) | $3.79 M(+2390.8%) |
| June 2016 | - | $735.00 K(-178.9%) | $152.00 K(-109.1%) |
| Mar 2016 | - | -$931.00 K(-185.9%) | -$1.66 M(-26.8%) |
| Dec 2015 | -$2.27 M(-196.9%) | $1.08 M(-247.3%) | -$2.27 M(-20.9%) |
| Sept 2015 | - | -$736.00 K(-31.9%) | -$2.88 M(+42.5%) |
| June 2015 | - | -$1.08 M(-29.9%) | -$2.02 M(<-9900.0%) |
| Mar 2015 | - | -$1.54 M(-419.7%) | $15.00 K(-99.4%) |
| Dec 2014 | $2.35 M(-1.5%) | $482.00 K(+295.1%) | $2.35 M(-9.1%) |
| Sept 2014 | - | $122.00 K(-87.2%) | $2.58 M(-23.8%) |
| June 2014 | - | $952.00 K(+20.5%) | $3.38 M(+14.8%) |
| Mar 2014 | - | $790.00 K(+10.3%) | $2.95 M(+23.9%) |
| Dec 2013 | $2.38 M(-61.8%) | $716.00 K(-22.8%) | $2.38 M(-0.4%) |
| Sept 2013 | - | $927.00 K(+79.7%) | $2.39 M(-30.2%) |
| June 2013 | - | $516.00 K(+132.4%) | $3.43 M(-33.4%) |
| Mar 2013 | - | $222.00 K(-69.4%) | $5.14 M(-17.4%) |
| Dec 2012 | $6.23 M | $726.00 K(-63.0%) | $6.23 M(-17.4%) |
| Sept 2012 | - | $1.96 M(-12.2%) | $7.54 M(+16.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2012 | - | $2.23 M(+70.9%) | $6.50 M(+18.3%) |
| Mar 2012 | - | $1.31 M(-35.8%) | $5.50 M(+12.4%) |
| Dec 2011 | $4.89 M(-55.7%) | $2.04 M(+120.5%) | $4.89 M(-24.2%) |
| Sept 2011 | - | $924.00 K(-24.8%) | $6.46 M(-10.3%) |
| June 2011 | - | $1.23 M(+75.6%) | $7.20 M(-18.4%) |
| Mar 2011 | - | $700.00 K(-80.6%) | $8.83 M(-20.0%) |
| Dec 2010 | $11.03 M(-27.1%) | $3.60 M(+115.9%) | $11.03 M(-22.6%) |
| Sept 2010 | - | $1.67 M(-41.6%) | $14.24 M(-3.3%) |
| June 2010 | - | $2.86 M(-1.6%) | $14.73 M(+4.8%) |
| Mar 2010 | - | $2.90 M(-57.4%) | $14.04 M(-7.2%) |
| Dec 2009 | $15.13 M(+91.7%) | $6.82 M(+217.0%) | $15.13 M(-7.0%) |
| Sept 2009 | - | $2.15 M(-1.2%) | $16.27 M(+27.2%) |
| June 2009 | - | $2.18 M(-45.5%) | $12.79 M(+11.3%) |
| Mar 2009 | - | $3.99 M(-49.8%) | $11.49 M(+45.6%) |
| Dec 2008 | $7.89 M(-25.5%) | $7.96 M(-697.2%) | $7.89 M(+46.4%) |
| Sept 2008 | - | -$1.33 M(-252.2%) | $5.39 M(-40.7%) |
| June 2008 | - | $875.00 K(+121.0%) | $9.09 M(-6.2%) |
| Mar 2008 | - | $396.00 K(-92.7%) | $9.69 M(-8.6%) |
| Dec 2007 | $10.60 M(+77.6%) | $5.45 M(+130.4%) | $10.60 M(+83.5%) |
| Sept 2007 | - | $2.37 M(+60.9%) | $5.78 M(-12.5%) |
| June 2007 | - | $1.47 M(+12.1%) | $6.60 M(+29.3%) |
| Mar 2007 | - | $1.31 M(+109.3%) | $5.10 M(-14.5%) |
| Dec 2006 | $5.97 M(+45.8%) | $627.00 K(-80.3%) | $5.97 M(-35.9%) |
| Sept 2006 | - | $3.19 M(<-9900.0%) | $9.32 M(+79.8%) |
| June 2006 | - | -$24.00 K(-101.1%) | $5.18 M(-19.9%) |
| Mar 2006 | - | $2.18 M(-45.2%) | $6.47 M(+58.0%) |
| Dec 2005 | $4.09 M(-51.4%) | $3.97 M(-520.1%) | $4.09 M(+34.2%) |
| Sept 2005 | - | -$946.00 K(-174.8%) | $3.05 M(-44.6%) |
| June 2005 | - | $1.26 M(-741.6%) | $5.51 M(-20.9%) |
| Mar 2005 | - | -$197.00 K(-106.7%) | $6.97 M(-17.3%) |
| Dec 2004 | $8.43 M(+1141.1%) | $2.93 M(+93.4%) | $8.43 M(+40.1%) |
| Sept 2004 | - | $1.51 M(-44.4%) | $6.02 M(+47.4%) |
| June 2004 | - | $2.72 M(+116.5%) | $4.08 M(+157.9%) |
| Mar 2004 | - | $1.26 M(+142.4%) | $1.58 M(+133.1%) |
| Dec 2003 | $679.00 K(-233.9%) | $519.00 K(-223.9%) | $679.00 K(-155.5%) |
| Sept 2003 | - | -$419.00 K(-286.2%) | -$1.22 M(+615.2%) |
| June 2003 | - | $225.00 K(-36.4%) | -$171.00 K(+9.6%) |
| Mar 2003 | - | $354.00 K(-125.6%) | -$156.00 K(-69.2%) |
| Dec 2002 | -$507.00 K(-122.5%) | -$1.38 M(-318.5%) | -$507.00 K(-126.1%) |
| Sept 2002 | - | $633.00 K(+163.8%) | $1.95 M(+206.9%) |
| June 2002 | - | $240.00 K(+7900.0%) | $634.20 K(-39.0%) |
| Mar 2002 | - | $3000.00(-99.7%) | $1.04 M(-53.9%) |
| Dec 2001 | $2.26 M(+48.8%) | $1.07 M(-257.6%) | $2.26 M(+90.2%) |
| Sept 2001 | - | -$679.00 K(-205.1%) | $1.19 M(-36.4%) |
| June 2001 | - | $646.00 K(-47.0%) | $1.86 M(+53.0%) |
| Mar 2001 | - | $1.22 M | $1.22 M |
| Dec 2000 | $1.52 M(-41.5%) | - | - |
| Dec 1999 | $2.59 M(+9507.4%) | - | - |
| Dec 1998 | $27.00 K | - | - |
FAQ
- What is Harvard Bioscience annual free cash flow?
- What is the all time high annual FCF for Harvard Bioscience?
- What is Harvard Bioscience annual FCF year-on-year change?
- What is Harvard Bioscience quarterly free cash flow?
- What is the all time high quarterly FCF for Harvard Bioscience?
- What is Harvard Bioscience quarterly FCF year-on-year change?
- What is Harvard Bioscience TTM free cash flow?
- What is the all time high TTM FCF for Harvard Bioscience?
- What is Harvard Bioscience TTM FCF year-on-year change?
What is Harvard Bioscience annual free cash flow?
The current annual FCF of HBIO is $11.72 M
What is the all time high annual FCF for Harvard Bioscience?
Harvard Bioscience all-time high annual free cash flow is $15.13 M
What is Harvard Bioscience annual FCF year-on-year change?
Over the past year, HBIO annual free cash flow has changed by +$12.15 M (+2775.11%)
What is Harvard Bioscience quarterly free cash flow?
The current quarterly FCF of HBIO is -$1.95 M
What is the all time high quarterly FCF for Harvard Bioscience?
Harvard Bioscience all-time high quarterly free cash flow is $7.96 M
What is Harvard Bioscience quarterly FCF year-on-year change?
Over the past year, HBIO quarterly free cash flow has changed by -$5.91 M (-149.32%)
What is Harvard Bioscience TTM free cash flow?
The current TTM FCF of HBIO is $160.00 K
What is the all time high TTM FCF for Harvard Bioscience?
Harvard Bioscience all-time high TTM free cash flow is $16.27 M
What is Harvard Bioscience TTM FCF year-on-year change?
Over the past year, HBIO TTM free cash flow has changed by -$10.76 M (-98.53%)